Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 1739: Intratumoral INTASYL™ self-delivering RNAi targeting PD-1 provides in vivo tumor control and mechanistic modulation of tumor microenvironment analogous to that of systemic anti-PD-1 antibody

Cancer Res (2021) 81 (13_Supplement): 1739.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal